Beijing Chao-Yang Hospital

Company snapshot

Founded on February 24, 1958, Beijing Chaoyang Hospital affiliated to Capital Medical University is a Level III A general hospital integrating medical, teaching, scientific research and prevention subordinate to the Beijing Municipal Healthcare Bureau. Served as the third clinical hospital of the medical school of Capital Medical University, it is also the designated Category A medical institution

• 1 active pipeline program(s) linked via ClinicalTrials.gov.
• 1 trial update(s) in the last 12 months.

Public regulatory, clinical, patent, and corporate records for Beijing Chao-Yang Hospital. Not investment advice.

• What is Beijing Chao-Yang Hospital?

  Beijing Chao Yang is a pharma organization headquartered in CN. Primary therapeutic focus areas include Pneumocystis Pneumonia. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0 patent record(s) to this entity from public FDA, EMA, ClinicalTrials.gov, and USPTO

• Is Beijing Chao-Yang Hospital publicly traded?

  Beijing Chao-Yang Hospital appears in our database through regulatory marketing authorisation or clinical trial sponsor records; a US listed ticker is not shown for this entity.

• What drugs does Beijing Chao-Yang Hospital develop or market?

  We link 1 drug profile(s) where Beijing Chao-Yang Hospital is an originator or marketer in FDA or regional approval metadata. See the drug portfolio table on https://novapharmanews.com/companies/beijing-chao-yang-hospital#company-drugs.

• What are the latest developments for Beijing Chao-Yang Hospital?

  In the last 12 months our linked public records show 1 trial program update(s) and 0 US patent grant(s) tied to this profile.

• What therapeutic areas does Beijing Chao-Yang Hospital focus on?

  Beijing Chao-Yang Hospital focuses on Pneumocystis Pneumonia based on our analysis of their pipeline programs and drug development activities.